Antibody-Drug Conjugates and Gynecologic Cancer: What You Need to Know

Join Dr. Salani, Director of Gynecologic Oncology at UCLA, for an expert discussion on antibody-drug conjugates (ADCs) and their evolving role in the treatment of cervical, uterine, and ovarian cancers. This session will review the latest clinical evidence, emerging indications, patient selection, and practical considerations for incorporating ADCs into gynecologic oncology practice to help optimize patient care.